Characteristics of severe asthma with fungal sensitization.
暂无分享,去创建一个
T. Betsuyaku | Yusuke Suzuki | K. Izuhara | K. Fukunaga | K. Asano | F. Sakamaki | K. Sayama | K. Kamei | Morio Nakamura | Hidefumi Koh | T. Oguma | K. Masaki | A. Umeda | H. Kabata | T. Kamatani | Takashi Inoue | Y. Oyamada | R. Baba | M. Matsusaka | S. Ueda | T. Mochimaru | T. Tanosaki | Kengo Ohtsuka | Takashi Kamatani | Takae Tanosaki | Masako Matsusaka
[1] D. Larenas-Linnemann,et al. Clinical Evaluation and Management of Patients with Suspected Fungus Sensitivity. , 2016, The journal of allergy and clinical immunology. In practice.
[2] M. Taniguchi,et al. Serological diagnosis of allergic bronchopulmonary mycosis: Progress and challenges. , 2016, Allergology international : official journal of the Japanese Society of Allergology.
[3] N. Rezaei,et al. Serum IL-33 Is Elevated in Children with Asthma and Is Associated with Disease Severity , 2016, International Archives of Allergy and Immunology.
[4] M. Taniguchi,et al. Sensitization to fungal allergens: Resolved and unresolved issues. , 2015, Allergology international : official journal of the Japanese Society of Allergology.
[5] A. Bush,et al. Pediatric severe asthma with fungal sensitization is mediated by steroid-resistant IL-33 , 2015, The Journal of allergy and clinical immunology.
[6] Helen K. Reddel,et al. A summary of the new GINA strategy: a roadmap to asthma control , 2015, European Respiratory Journal.
[7] T. Betsuyaku,et al. Phenotype of asthma related with high serum periostin levels. , 2015, Allergology international : official journal of the Japanese Society of Allergology.
[8] J. Girard,et al. IL-33: an alarmin cytokine with crucial roles in innate immunity, inflammation and allergy. , 2014, Current opinion in immunology.
[9] S. Akthar,et al. Alternaria-derived serine protease activity drives IL-33–mediated asthma exacerbations , 2014, The Journal of allergy and clinical immunology.
[10] M. Kanazawa,et al. Reference values for spirometry, including vital capacity, in Japanese adults calculated with the LMS method and compared with previous values. , 2014, Respiratory investigation.
[11] Liang Dong,et al. IL-33 promotes airway remodeling and is a marker of asthma disease severity , 2014, The Journal of asthma : official journal of the Association for the Care of Asthma.
[12] A. Wardlaw,et al. Fungal allergy in asthma–state of the art and research needs , 2014, Clinical and Translational Allergy.
[13] F. Nomura,et al. Glucoamylase is a major allergen of Schizophyllum commune , 2014, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[14] E. Bleecker,et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma , 2013, European Respiratory Journal.
[15] T. Betsuyaku,et al. Thymic stromal lymphopoietin induces corticosteroid resistance in natural helper cells during airway inflammation , 2013, Nature Communications.
[16] A. Bush,et al. IL-33 promotes airway remodeling in pediatric patients with severe steroid-resistant asthma. , 2013, The Journal of allergy and clinical immunology.
[17] Julie M. Kezik,et al. Household mold and dust allergens: exposure, sensitization and childhood asthma morbidity. , 2012, Environmental research.
[18] E. Bel,et al. Current treatment of severe asthma , 2012, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[19] S. Wenzel. Asthma phenotypes: the evolution from clinical to molecular approaches , 2012, Nature Medicine.
[20] Efficacy of using the Japanese version of the asthma control test for determing the level of asthma control in clinical settings. , 2012, Allergology international : official journal of the Japanese Society of Allergology.
[21] Nicola A Hanania,et al. Lebrikizumab treatment in adults with asthma. , 2011, The New England journal of medicine.
[22] H. Kita,et al. Human Eosinophil Innate Response to Alternaria Fungus through Protease-Activated Receptor-2 , 2011, International Archives of Allergy and Immunology.
[23] P. Stenner,et al. Measuring asthma‐specific quality of life: structured review , 2011, Allergy.
[24] R. Agarwal,et al. Severe asthma and fungi: current evidence. , 2011, Medical mycology.
[25] S. Kato,et al. Periostin, a matrix protein, is a novel biomarker for idiopathic interstitial pneumonias , 2010, European Respiratory Journal.
[26] N. Goplen,et al. Combined sensitization of mice to extracts of dust mite, ragweed, and Aspergillus species breaks through tolerance and establishes chronic features of asthma. , 2009, The Journal of allergy and clinical immunology.
[27] D. Denning,et al. The link between fungi and severe asthma: a summary of the evidence , 2006, European Respiratory Journal.
[28] Bénédicte Leynaert,et al. Sensitisation to airborne moulds and severity of asthma: cross sectional study from European Community respiratory health survey , 2002, BMJ : British Medical Journal.
[29] P. Black,et al. Sensitivity to fungal allergens is a risk factor for life‐threatening asthma , 2000, Allergy.
[30] V. Persky,et al. Effect of environmental molds on risk of death from asthma during the pollen season. , 1995, The Journal of allergy and clinical immunology.
[31] S. Leeder,et al. Importance of house dust mite and Alternaria allergens in childhood asthma: an epidemiological study in two climatic regions of Australia , 1993, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[32] G. Guyatt,et al. Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials. , 1992, Thorax.
[33] K. Offord,et al. Exposure to an aeroallergen as a possible precipitating factor in respiratory arrest in young patients with asthma. , 1991, The New England journal of medicine.